Dr. Pamela Wartian Smith, M.D., MPH, MS, a renowned expert in hormone health, will present
on key topics including endocrine disruptors, women’s hormones, and hypothyroidism. She will
explore how environmental chemicals—such as BPA from plastics—disrupt hormone balance,
impacting the hypothalamic-pituitary-gonadal axis and pituitary-adrenal function.
Dr. Shimek is a Functional Medicine Practitioner and Naturopathic Physician celebrated for her expertise in women’s health, biohacking, and epigenetics.
Dr. Brownstein will be presenting at the 2025 Annual Restorative Medicine Conference on the topic of A Holistic Approach to Autoimmune Thyroid.
This case study reports on the novel combination of three treatments for cognitive decline in a 79-year-old male: therapeutic plasma exchange (TPE), peptides, and human umbilical cord tissue mesenchymal stem cells and exosomes (UCT-MSC-EXs).
To our knowledge, this is the first case study to report on reducing biological age, increasing telomere length, and improving cognition using this unique combination of therapies in a patient with mild to moderate cognitive decline.
The prevalence of organ-specific and systemic autoimmune conditions is increasing worldwide. Certain phytoconstituents may be helpful as part of a therapeutic protocol for autoimmune rheumatic conditions, as they have been shown to have immunoregulatory effects in experimental and pre-clinical studies.
A combination of genetic, epigenetic, and environmental factors is thought to contribute to the development of rheumatoid arthritis.
The need for safe and effective therapies to promote cognitive health, and the growing interest in healthy longevity have brought the therapeutic promise of neuropeptides increasingly to the forefront of restorative medicine practice.
This case study reports on the novel combination of three treatments for cognitive decline in a 79-year-old male: therapeutic plasma exchange (TPE), peptides, and human umbilical cord tissue mesenchymal stem cells and exosomes (UCT-MSC-EXs).
To our knowledge, this is the first case study to report on reducing biological age, increasing telomere length, and improving cognition using this unique combination of therapies in a patient with mild to moderate cognitive decline.
A growing body of evidence shows that susceptibility to adult-onset CVD begins in early life, even in utero, presumably as a result of epigenetic dysregulation.
A growing body of evidence shows that susceptibility to adult-onset CVD begins in early life, even in utero, presumably as a result of epigenetic dysregulation.
Over time, increased hemodynamic stress on the heart from high blood pressure leads to the compensatory development of left ventricular hypertrophy.
Mounting evidence suggests that some viruses can persist in heart tissue after an initial infection, and become reactivated under certain conditions, triggering a cell-mediated immune response that leads to myocarditis and, potentially, dilated cardiomyopathy.
